Is AMRX Stock Undervalued? Sales Multiple, Target, Upside | Collector
Quartz
Is AMRX Stock Undervalued? Sales Multiple, Target, Upside
Amneal Pharmaceuticals trades below peers on sales multiple despite strong gains, with a $14 target hinging on execution, mix shift, and margin strength.
Quartz